These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 25998140)

  • 1. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern.
    Hasdemir C; Juang JJ; Kose S; Kocabas U; Orman MN; Payzin S; Sahin H; Celen C; Ozcan EE; Chen CJ; Gunduz R; Turan OE; Senol O; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1078-1092. PubMed ID: 29953624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of atrial functional remodeling in patients with atrioventricular nodal reentrant tachycardia with and without drug-induced type 1 Brugada pattern: A case-control study.
    Kocabaş U; Payzın S; Hasdemir C
    J Clin Ultrasound; 2021 Jul; 49(6):573-579. PubMed ID: 33599988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.
    Sarica AS; Bor S; Orman MN; Barajas-Martinez H; Juang JJ; Antzelevitch C; Hasdemir C
    Am J Cardiol; 2021 Jul; 151():51-56. PubMed ID: 34034907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous atrioventricular nodal reentrant tachycardia in patients with idiopathic ventricular arrhythmias: the incidence, clinical, and electrophysiologic characteristics.
    Hasdemir C; Alp A; Simsek E; Kose N; Aydin M; Payzin S
    J Cardiovasc Electrophysiol; 2013 Dec; 24(12):1370-4. PubMed ID: 24016309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontact three-dimensional mapping guides catheter ablation of difficult atrioventricular nodal reentrant tachycardia.
    Lee PC; Tai CT; Lin YJ; Liu TY; Huang BH; Higa S; Yuniadi Y; Lee KT; Hwang B; Chen SA
    Int J Cardiol; 2007 May; 118(2):154-63. PubMed ID: 17023073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN10A variants associated with Brugada syndrome.
    Fukuyama M; Ohno S; Makiyama T; Horie M
    Europace; 2016 Jun; 18(6):905-11. PubMed ID: 25842276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
    Liu S; Yuan S; Hertervig E; Kongstad O; Olsson SB
    J Electrocardiol; 2001 Oct; 34(4):295-301. PubMed ID: 11590556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway.
    Letsas KP; Weber R; Siklody CH; Mihas CC; Stockinger J; Blum T; Kalusche D; Arentz T
    Acta Cardiol; 2010 Apr; 65(2):171-6. PubMed ID: 20458824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency current catheter ablation of accessory atrioventricular pathways.
    Trajkov I; Kovacevic D; Boskov V; Poposka L; Gjorgov N
    Prilozi; 2006 Dec; 27(2):71-87. PubMed ID: 17211293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic variables associated with underlying Brugada syndrome or drug-induced Type 1 Brugada pattern in patients with slow/fast atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Sahin H; Duran G; Orman MN; Kocabas U; Payzin S; Aydin M; Antzelevitch C
    J Arrhythm; 2022 Aug; 38(4):633-641. PubMed ID: 35936048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.